Molecular diagnosis is rarely established in 46,XX testicular (T) disorder of sex development (DSD) individuals with atypical genitalia. The Wilms' tumour factor-1 (WT1) gene is involved in early gonadal development in both sexes. Classically, WT1 deleterious variants are associated with 46,XY disorders of sex development (DSD) because of gonadal dysgenesis. We report a novel frameshift WT1 variant identified in an SRY-negative 46,XX testicular DSD girl born with atypical genitalia. Target massively parallel sequencing involving DSD-related genes identified a novel heterozygous WT1 c.1453_1456del; p.Arg485Glyfs*14 variant located in the fourth zinc finger of the protein which is absent in the population databases. Segregation analysis and microsatellite analysis confirmed the de novo status of the variant that is predicted to be deleterious by in silico tools and to increase WT1 target activation in crystallographic model. This novel and predicted activating frameshift WT1 variant leading to the 46,XX testicular DSD phenotype includes the fourth zinc-finger DNA-binding domain defects in the genetic aetiology of 46,XX DSD. 
| Genetic analysis
All research procedures followed the tenets of the Declaration of Helsinki, were approved by the local Ethics Committee with informed consent prior to genetic testing.
We designed an amplicon-based capture panel against exonic regions of 63 genes known to be associated with human DSDs and also candidate genes for DSD etiology 7 (see Table S1 , Supporting Information).
Target sequences were captured using a custom Sure Select Target Enrichment System Kit (Agilent Technologies, Santa Clara, California).
Sequencing was performed on the Illumina MiSeq platform (San Diego, California) (see Supporting Information).
Sanger sequencing confirmed the potentially pathogenic variant identified by targeted massively parallel sequencing and for segregation analysis. The identified variant was classified according to the American College of Medical Genetics (ACMG) criteria. 8 Microsatellite analysis with 5 markers (deCODE, Généthon, and
Marshfield) was performed to assess disease haplotypes in the 
| In silico modelling of the p.Arg485Glyfs*14 variant
The effect of the mutation on protein stability and function was calculated using the COFACTOR server (I-TASSER), 9 FoldX RepairPDB, 10 and
BuildModel commands (YASARA). 11 The in silico interaction energies between the p.Arg485Gly WT1 region and DNA fragments for NR5A1, FOXL2, and WNT4 were calculated using the FoldX interaction energy.
| RESULTS
Target sequencing analysis identified a novel heterozygous frameshift WT1 c.1453_1456del variant (see Figure S1 ), which is located in exon 
| DISCUSSION
We described an SRY-negative 46,XX T-DSD girl with atypical genitalia harbouring a novel and de novo frameshift WT1 variant. This presentation is very unusual for 46,XX T-DSD patients. Classically, these patients are characterised by a 46,XX karyotype, male external genitalia, small testis, and the absence of Mullerian structures. 13 Approximately, 85% of the patients are diagnosed after puberty because of their small testes, gynecomastia, and infertility. The other 15% of patients are diagnosed at birth based on atypical genitalia. 13 In 46,XY individuals, pathogenic WT1 allelic variants are responsible for Denys-Drash and Frasier syndromes, which are characterised by gonadal dysgenesis, early childhood cortico-resistant nephrotic proteinuria followed by renal failure, and Wilms' tumour or gonadoblastoma. 5, 6 Denys-Drash variants are generally located in exons 8 and 9 and Frasier variants are located in intron 9.
In 46,XX individuals, two deleterious heterozygous WT1 variants located outside the zinc-finger domains were previously described in two patients with premature ovarian insufficiency (POI). 14 Another two 46,XX gonadal dysgenesis patients with steroid-resistant nephropathy harboured variants located in exon 9 of WT1. 15, 16 There is no description of atypical genitalia in any of these affected female patients.
The first description of a WT1 variant causing 46,XX T-DSD was reported in 2017. 17 The missense WT1 p.Arg495Gly variant was identified in a syndromic boy with microcephaly, normal kidney function, male external genitalia, dysgenic testis, and a small uterus.
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These findings resemble those reported for the NR5A1 p.
Arg92Trp pathogenic variant. This variant were also first associated with 46,XY DSD and POI 18 in 46,XX patients. Later, the NR5A1 p.
Arg92Trp variant was identified in familial and sporadic patients with 46,XX T and OT-DSD. [18] [19] [20] Interestingly, the previously and presently described WT1 alterations associated with 46,XX T-DSD are located in the fourth zincfinger DNA-binding domain of the WT1 protein.
There is one reported pathogenic variant, the p.X518Trp located in exon 10 of WT1 in two female affected individuals. 21 In contrast to our frameshift variant, this variant leads to WT1 protein elongation of 22 amino acids but preserves fourth zinc-finger DNA-binding domain.
The 46,XX T-DSD phenotype can be explained based on the WT1 role of in the ovarian determination pathway. 22 A previous study showed that the number of FOXL2-positive cells was dramatically reduced and SOX9-positive cells were observed in Wt1-deficient XX mice gonads. 23 In addition, the expression of ovary-specific genes (A) (B) FIGURE 3 Schematic overview of the signalling pathway of ovarian development (A) and proposed mechanism of 46,XX DSD testicular in patients with heterozygous WT1 variant in exon 10 (B) in 46,XX individuals, FOXL2 transcriptionally represses NR5A1 expression by antagonising WT1 during gonadal development, leading to suppression of the male pathway and activation of the ovarian determination cascade. We hypothesised that the WT1 p.R485G*fs14 variant, leads to NR5A1 expression, resulting in SOX9 up-regulation and testicular development in this 46,XX T-DSD girl (Wnt4, Rspo1, Foxl2, Bmp2, and Fst) was also significantly reduced, whereas testis-specific genes expression was increased in Wt1-deficient XX gonads at E13.5.
23
The mutant p.Arg485Glyfs*14 WT1 protein probably leads to an imbalance between the female and male gonadal determination pathway. The increased binding enthalpy of WT1 p.Arg485Glyfs*14, observed in the in silico model, probably leads to NR5A1 overexpression followed by SOX9 up-regulation and testis differentiation (Figure 3) . Further in vitro studies are necessary to confirm this hypothesis.
The intriguing absence of renal manifestations of our patient might be because of her young age. The only reported variant in exon 10 (WT1 p.X518Trp) led to progressive proteinuria in the female index case and her mother, reaching end-stage renal disease at 15 and 22 years old, respectively. 21 The propositus also presented with
Wilms' tumour at 9 years old. These data indicate the need of followup of these individuals.
| CONCLUSION
The identification of a novel and predicted activating frameshift WT1 variant leading to the 46,XX testicular DSD phenotype includes the fourth zinc-finger DNA-binding domain defects in the genetic aetiology of 46,XX DSD.
